Patents by Inventor Graham Pointer

Graham Pointer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020128945
    Abstract: A computerised trading system for the trading of financial instruments or commodities which enables anonymous presentation of quotes on a workstation while still allowing the workstation to filter available quotes for display, on the basis of the nature of the originating party. A central server or network connects a plurality of workstations, each associated with a respective trading floor or institution. For each trading floor or institution, generalized institution status indicators are used to provide display filtration criteria, each indicator indicating a non-specific attribute of the respective institution.
    Type: Application
    Filed: January 3, 2001
    Publication date: September 12, 2002
    Inventors: Peter Ian Moss, David Martin Walters, Edward Graham Pointer
  • Publication number: 20010024824
    Abstract: Methods and compositions are described for the treatment of type I insulin-dependent diabetes mellitus and other conditions using newly identified stem cells that are capable of differentiation into a variety of pancreatic islet cells, including insulin-producing beta cells, as well as hepatocytes. Nestin has been identified as a molecular marker for pancreatic stem cells, while cytokeratin-19 serves as a marker for a distinct class of islet ductal cells. Methods are described whereby nestin-positive stem cells can be isolated from pancreatic islets and cultured to obtain further stem cells or pseudo-islet like structures. Methods for ex vivo differentiation of the pancreatic stem cells are disclosed. Methods are described whereby pancreatic stem cells can be isolated, expanded, and transplanted into a patient in need thereof, either allogeneically, isogeneically or xenogenically, to provide replacement for lost or damaged insulin-secreting cells or other cells.
    Type: Application
    Filed: December 6, 2000
    Publication date: September 27, 2001
    Inventors: Peter Ian Moss, David Martin Walters, Graham Pointer